BAY58-2667
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAY58-2667, covering 2015-10-08 to 2017-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667 [Phase 2]